ArticleGeriatrics & gerontology international2026
Nocturia ≥ 3/Night and 5-Year Fragility Fracture Risk in Older Urology Outpatients.
Article in Geriatrics & gerontology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo evaluate whether nocturia ≥ 3/night stratifies 5-year fragility-fracture risk in older urology outpatients and to explore its prognostic performance alongside the N-QoL and IPSS.
methodsWe conducted a retrospective cohort study of urology outpatients aged ≥ 65 years at Hachinohe City Hospital, Japan, between 2015 and 2024. After exclusion of patients with prior fragility fracture, bone metastasis, or pathological fracture, and application of a 3-month landmark, 2290 participants were included. The primary outcome was first non-pathological fragility fracture. Bone metastasis and death were treated as competing events. Fine-Gray subdistribution hazard models were adjusted for age, sex, hypertension, and diabetes. To complement effect estimates, standardized 5-year cumulative incidence was estimated using model-based standardization.
resultsOver a median follow-up of 48.1 months, 98 fragility fractures occurred; 42 bone metastases and 18 deaths were treated as competing events. Nocturia ≥ 3/night was associated with higher fracture risk than nocturia < 3/night (subdistribution hazard ratio [sHR] 2.11, 95% confidence interval [CI] 1.41-3.17). Impaired N-QoL was also associated with higher risk (sHR 1.92, 95% CI 1.12-3.30), whereas severe IPSS showed a weaker association (sHR 1.79, 95% CI 1.00-3.22). The standardized 5-year fracture risk was 9.8% for nocturia ≥ 3/night and 4.8% for nocturia < 3/night, corresponding to an absolute difference of 5.0 percentage points.
conclusionsNocturia ≥ 3/night was associated with higher 5-year fragility-fracture risk and may prompt consideration of falls and bone-health assessment in older urology outpatients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.